BRCA1 and breast carcinoma: This was higher than the germline BRCA1/2 mutation rates (2.2%) previously reported in a cohort of 645 unselected Chinese breast cancer women[4], and than that (3.0%) in 471 unselected Korea breast cancer patients using less sensitive methods[23].